Press Area

Press release list of thematic 'Cancer'



Antibiotics affect the efficacy of immunotherapy

November 03 2017

A study published in the journal Science by a research team from Gustave Roussy, INSERM, INRA, AP-HP, IHU Médiaterranée Infections* and Paris-Sud University shows that prescribed antibiotics impair the efficacy of immunotherapy in cancer...
Read more...

Two blood tests for predicting the efficacy of a lung cancer treatment

Two blood tests for predicting the efficacy of a lung cancer treatment

May 02 2017

ALK gene rearrangement is observed in 4% of non-small-cell lung cancer (NSCLC) patients. Researchers from Gustave Roussy, Inserm and Université Paris-Sud, have shown that two blood samples can now predict the efficacy of treatment (crizotinib). Th...
Read more...

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

April 27 2017

Teams from AP-HP, INRA, Gustave Roussy and Inserm can demonstrate the role of microbiota in the response of immunotherapy for cancer. They show that in man, the composition of gut microbiota can help to identify the patients who will respond favou...
Read more...


New immunotherapy-based approach for post-transplant leukaemia relapse

October 06 2016

An Inserm team from the Mondor Institute for Biomedical Research (IMRB) has just identified a key switch in the immune response, and proposes a new immunotherapy-based approach for combating leukaemia. And maybe other cancers in time. This work is...
Read more...


The gut microbiota to the rescue of chemotherapies

October 05 2016

Two species of bacteria present in the gut boost the efficacy of cyclophosphamide-based chemotherapies by optimising the antitumour immunity induced by this drug. This is reported by researchers from Inserm, Gustave Roussy, CNRS, Institut Pasteur...
Read more...
^ Top of page